Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-24 @ 5:37 PM
NCT ID:
NCT04027868
Eligibility Criteria:
Inclusion Criteria:
* Patient older than 18 years.
* Patient with ovarian and/or primitive peritoneal and/or fallopian tubes carcinoma, histologically confirmed, with an advanced stage at diagnosis (stage III to IV FIGO 2014)
* Patient in first line therapy
* Available tumor sample fixed in formalin and included in paraffin (FFPE):
* in pre-chemotherapy, insofar as possible
* having a sufficient tumor surface, with a final cellularity of at least 20%
* Identification of a molecular genetics' cancer platform participant in GREAT and an onco-geneticists team working with the investigator team
* Patient consenting her data to be collected and submitted through an automated processing
* Patient beneficiary from the French social security
Exclusion Criteria:
* Patient with a mucinous ovarian carcinoma
* Patient pregnant or breastfeeding
* Patient under legal protection (guardianship or court order) or unable to consent
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04027868
Study Brief:
Protocol Section:
NCT04027868